2019
DOI: 10.3389/fcomm.2019.00014
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive Reserve and Its Effect in Older Adults on Retrieval of Proper Names, Logo Names and Common Nouns

Abstract: Previous studies showed that high Cognitive Reserve (CR, years of education and experience and knowledge acquired in life) is correlated with language proficiency as measured with vocabulary size, verbal analogy, and semantic processing. The aim of the present study is to investigate the relationship between CR and the ability in retrieving different categories of words: Proper Names, Logo Names, and Common Nouns. The hypothesis is that CR contributes more in retrieving Common Nouns and Logo Names which are hi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
17
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
3

Relationship

6
2

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 53 publications
(88 reference statements)
1
17
0
Order By: Relevance
“…MoCA is, to date, used worldwide by psychologists, neurologists, geriatricians, occupational and speech therapists (e.g., O'Driscoll & Shaikh, 2017) and serves for a general screening, usually followed by a more detailed neuropsychological assessment of the cognitive profile. Initially created to distinguish among individuals with MCI, Alzheimer's disease, and healthy controls, now widely used for assessing the cognitive profile of healthy participants (Chen et al, 2020;Montemurro et al, 2019a), populations with pathological aging (Roalf et al, 2013) and neurodegenerative disorders like Parkinson's Disease (Biundo et al, 2014;Montemurro et al, 2019b), Multiple Sclerosis (e.g., Al-Sharman et al, 2019), and Human immunodeficiency virus (HIV) (Rosca et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…MoCA is, to date, used worldwide by psychologists, neurologists, geriatricians, occupational and speech therapists (e.g., O'Driscoll & Shaikh, 2017) and serves for a general screening, usually followed by a more detailed neuropsychological assessment of the cognitive profile. Initially created to distinguish among individuals with MCI, Alzheimer's disease, and healthy controls, now widely used for assessing the cognitive profile of healthy participants (Chen et al, 2020;Montemurro et al, 2019a), populations with pathological aging (Roalf et al, 2013) and neurodegenerative disorders like Parkinson's Disease (Biundo et al, 2014;Montemurro et al, 2019b), Multiple Sclerosis (e.g., Al-Sharman et al, 2019), and Human immunodeficiency virus (HIV) (Rosca et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Another important point is that scores of screenings, as is the case for all cognitive tests, have so far only been adjusted for age, education, and sex (Strauss et al., 2006 ), although other variables may be at play and influence cognition (e.g., sociobehavioral or socioeconomic factors Fratiglioni et al., 2004 ; Livingston et al., 2017 ; Mondini et al., 2022 ; Ward et al., 2015 ). From this perspective, education is only one component of the concept of Cognitive Reserve (CR, Stern, 2003 ), which is well recognized as a comprehensive measure of abilities and knowledge acquired during life (Stern & Barulli, 2009 ), and as a modulator of cognitive performance (Lojo‐Seoane et al., 2018 ; Mitchell et al., 2012 ; Montemurro et al., 2019 ; Steffener & Stern, 2012 ). CR is considered a protective factor against major neurocognitive decline (Mondini et al., 2022 ), whereas in other pathologies, CR shows a positive effect on recovery after brain damage (Hindle et al., 2014 ; Menardi et al., 2020 ; Nunnari et al., 2014 ).…”
Section: Introductionmentioning
confidence: 99%
“…MoCA is, to date, used worldwide by psychologists, neurologists, geriatricians, occupational and speech therapists (e.g., O'Driscoll & Shaikh, 2017) and serves for a general screening, usually followed by a more detailed neuropsychological assessment of the cognitive pro le. Initially created to distinguish among individuals with MCI, Alzheimer's disease, and healthy controls, now widely used for assessing the cognitive pro le of healthy participants (Chen et al, 2020;Montemurro, Mondini, Crovace, & Jarema, 2019), populations with pathological aging (Roalf et al, 2013) and neurodegenerative disorders like Parkinson's Disease (Biundo et al, 2014;, Multiple Sclerosis (e.g., Al-Sharman et al, 2019), and Human immunode ciency virus (HIV) (Rosca, Albarqouni, & Simu, 2019).…”
Section: Introductionmentioning
confidence: 99%